Popular Weight Loss Drugs Now for Patients With Cancer?September 30, 2024Breast CancerPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTPreventive CareNonmelanoma Skin CancerNeuro-oncology
FDA Panel Votes for Limits on Gastric, Esophageal Cancer ImmunotherapySeptember 30, 2024Gastrointestinal CancerGastroenterologyPractice ManagementImmunotherapyPatient & Survivor Care
First Hike of Medicare Funding for Residencies in 25 Years Aims to Help ShortagesSeptember 27, 2024Practice Management
FDA Okays Osimertinib After CRT in Locally Advanced, Unresectable NSCLCSeptember 27, 2024Lung CancerPatient & Survivor CarePractice Management
Sex and Gender Influence Outcomes in Colorectal CancerSeptember 27, 2024Gastrointestinal CancerGastroenterology
Survival Outcomes in Hepatocellular Carcinoma Patients Show Improvement Over TimeSeptember 26, 2024Patient & Survivor CareGastrointestinal CancerGastroenterology
Does Medicare Advantage Offer Higher-Value Chemotherapy?September 26, 2024Practice ManagementPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTBreast CancerCNS/Brain CancerFollicular Lymphoma
AACR Cancer Progress Report: Big Strides and Big GapsSeptember 26, 2024Patient & Survivor CareMelanomaNonmelanoma Skin CancerPreventive CareLung CancerNeuro-oncologyPractice Management
Screening Identifies Familial Risk for Hereditary Breast and Ovarian Cancer in Large Health SystemSeptember 26, 2024Breast CancerPreventive Care
FDA’s Stricter Regulation of Lab-Developed Tests Faces Lawsuits and Lingering ConcernsSeptember 24, 2024Practice Management
FDA Expands Indication for Amivantamab in Lung CancerSeptember 23, 2024Lung CancerPractice Management
Black Women Have a Higher Risk for Death in BC SubtypesSeptember 23, 2024Breast CancerDiversity in MedicinePatient & Survivor Care
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast CancerSeptember 23, 2024Breast CancerPatient & Survivor Care
